Effects of treatment with pentoxifylline on the cardiovascular manifestations of group B streptococcal sepsis in the piglet

Pediatric Research

Volumn 40, Issue 3, 1996, Pages 469-474

  Del Moral, Teresa ^a   Goldberg, Ronald N ^a   Urbon, Javier ^a   Suguihara, Cleide ^a   Martinez, Octavio ^a   Stein Streilein, Joan ^a   Feuer, William J ^a   Bancalari, Eduardo ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTERIAL GAS; ARTICLE; CONTROLLED STUDY; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SWINE; SYSTEMIC VASCULAR RESISTANCE;

EID: 0029811746     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199609000-00017     Document Type: Article

References (24)

1. Meadow W, Rudinsky B 1995 Inflammatory mediators and neonatal sepsis. Clin Perinatol 22:519-536
2. Tracey KJ, Lowry SF, Cerami A 1988 Cachectin/TNF in septic shock and septic adult respiratory distress syndrome. Am Rev Respir Dis 138:1377-1379
3. Gibson RL, Redding GJ, Henderson WR, Truog WE 1991 Effect of the tumor necrosis factor inhibitor pentoxifylline on hemodynamics and gas exchange. Am Rev Respir Dis 143:598-604
4. Fiedler VB, Loot I, Sander E, Voehringer V, Galanos C, Fournel M 1992 monoclonal antibody to tumor necrosis factor-α prevents lethal endotoxin sepsis in adult rhesus monkeys. J Lab Clin Med 120:574-588
5. Abraham E, Wunderik R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel R, Balk R, Alfred R, Pennington JS, Wherry JC 1995 Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome. JAMA 273:934-941
6. Noel P, Nelson S, Bokulic R, Bagby G, Lippton H, Lipcono G, Summer W 1989 Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality. Clin Res 37:31A(abstr)
7. Lilly CM, Sandhu JS, Ishizaka A, Harada H, Yonemaru M, Larrick JW, Shi T, O'Hanley TF, Raffin TA 1989 PTXF prevents tumor necrosis factor-induced lung injury. Am Rev Respir Dis 139:1361-1368
8. Sullivan GW, Carper TH, Novick W, Mandell GL 1988 Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun 56:1722-1729
9. Zheng H, Crowley J, Chan JC, Hoffman H, Hatherill JR, Ishizaka A, Raffin TA 1990 Attenuation of TNF-induced endothelial cells cytotoxicity and neutrophil chemiluminescence. Am Rev Respir Dis 142:1043-1078
10. Zabel P, Wolter DT, Schonhartin M, Schade UF 1989 Pentoxifylline suppresses endotoxin-induced TNF formation in men. In: On Pentoxifylline and Analogues Effects on Leukocyte Function. Saint Paul-de-Vence, France, p 50 (abstr)
11. Schroer RH 1985 Antithrombotic potential of pentoxifylline: a hemorheologically active drug. Angiology 36:387-389
12. del Moral T, Goldberg R, Suguihara C, Martinez O, Feuer WJ, Bancalari E 1992 Effects of pentoxifylline on the cardiovascular manifestations of group B streptococcal sepsis in the piglet. Pediatr Res 31:596-600
13. Fleiss JL 1986 The Design and Analysis of Clinical Experiments. Wiley, New York, p 188
14. Montravers P, Fagon JY, Gibert C, Blanchet F, Novara A, Chastre J 1993 Pilot study of cardiopulmonary risk from pentoxifylline in adult respiratory distress syndrome. Chest 103:1017-1022
15. Watanabe H, Furukana, Schira 1982 Cardiovascular effects of aminophylline and pentoxifylline on intact dogs and isolated dog atria. Jpn Heart J 23:235-243
16. Osiovich H, Goldberg R, Adams JA, Offenbacher S, Kuo G, Devia C, Suguihara C, Bancalari E 1989 Cardiovascular effects of TNF (r-TNF) in piglets. Pediatr Res 25:279A(abstr)
17. Truog WE, Gibson RL, Henderson WR, Redding GJ 1990 Tumor necrosis factor induced neonatal pulmonary hypertension: effects of dazmegrel pretreatment. Pediatr Res 27:466-471
18. Chick T, Scotto P, Icenoglem, Sikes W, Doyle P, Riedel C, Wood S, Loeppky JA 1988 Effects on pentoxifylline on pulmonary hemodynamics during acute hypoxia in anesthetized dogs. Am Rev Respir Dis 137:1099-1103
19. Hakim TS, Petrella J 1988 Attenuation of pulmonary and systemic vasoconstriction with pentoxifylline and aminophylline. Can J Physiol Pharmacol 66:396-401
20. Hakim TS 1988 Reversal of pulmonary hypoxic vasoconstriction with pentoxifylline and aminophylline in isolated lungs. Can J Physiol Pharmacol 66:146-151
21. Gibson RL, Truog WE, Henderson Jr WR, Redding GJ 1992 Group B streptococcal sepsis in piglets: effect of combined pentoxifylline and indomethacin pretreatment. Pediatr Res 31:222-227
22. 2, Pediatr Res 18:874-878
23. Bjornson S, Cave C, Bjornson A 1987 Effects of pentoxifylline on survival and chemotaxis of polymorphonuclear leukocytes in a rat model of bacterial peritonitis. In: Mandell GL, Novick WJ (eds) Pentoxifylline and Leukocyte Function. Hoechst-Roussel Pharmaceuticals, Somerville, NJ, pp 138-154
24. Schonharting MM, Schade UF 1989 The effect of pentoxifylline in septic shock: new pharmacological aspects of an established drug. J Med 20:97-105